Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Yoshitomi licenses immunosuppressant to Novartis

Oct. 13, 1997

Aviron updates vaccine clinical program

Oct. 10, 1997

Therapeutic Antibodies' CytoTAb enters clinical trials

Oct. 7, 1997

MOMP DNA immunization for chlamydial infections

Oct. 6, 1997

OraVax to market and distribute Evans Medical's yellow fever vaccine

Oct. 3, 1997

North American Vaccine advances with meningitis B vaccine

Oct. 2, 1997

Collaborators demonstrate protection against HSV with Cel-Sci vaccine

Oct. 1, 1997

LF-08-0299 both prevents and reverses kidney rejection in dogs

Sep. 30, 1997

FTY-720: novel immunosuppressant for combination therapy

Sep. 25, 1997

Twinrix approved for marketing in Canada

Sep. 25, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.